Description:
Global Atosiban Market: Introduction
Atosiban is a combined oxytocin or vasopressin V1A antagonist. Oxytocin causes uterine contractions and helps in preterm labor. The total atosiban dose should not exceed 330 mg for an individual. Several clinical trials have been carried out to determine the efficacy and the safety of Atosiban. For instance, Atosiban versus placebo, Atosiban versus beta-mimetics, and Atosiban versus nifedipine. Currently, no side-effects have been reported. Atosiban is licenced for use as a tocolytic.
Report Overview:
https://www.transparencymarketresearch.com/atosiban-market.html
Key Drivers of Global Atosiban Market
Prevalence of autism
According to The Centers for Disease Control and Prevention (CDC), autism prevalence increases by nearly 10% to 1 in 54 children in the U.S. In 2016, 1 in 54 children had a diagnosis of ASD by age 8, a 10% increase over 2014 when the estimate was 1 in 59.
According to The Autism Society of America, among boys aged eight years, the prevalence was 29.7 per 1,000, 4.3 times higher than the 6.9 per 1,000 prevalence among girls aged eight years. According to WHO-World Health Organization, it is estimated that worldwide one in 160 children has an Autism spectrum disorder-ASD.
Rise in preterm labor complications
According to WHO-World Health Organization, an estimate of 15 million babies are born preterm every year, and the number continues to rise. Preterm birth complications are the leading cause of death among children under 5 years of age, responsible for approximately 1 million deaths in 2015, i.e., 1 in 10 babies. Approximately 1 million children die each year due to complications of preterm birth. More than 60% of preterm births occur in Africa and South Asia; however, preterm birth is a truly global issue. 90% of extremely preterm born in low-income countries die within the first few days of life, and less than 10% of extremely preterm babies die in high-income settings. WHO is conducting two clinical trials, called the WHO ACTION Trials (Antenatal Corticosteroids for Improving Outcomes in preterm Newborns) for women at risk of preterm birth. According to Save the Children Federation, Inc., preterm birth is a leading cause of under-5 mortality, taking nearly 1 million lives every year, with the rate of preterm birth increasing in several countries.
North America to Account for Major Share of Global Atosiban Market
• North America is projected to account for a major share of the global Atosiban market during the forecast period. The market in the region is anticipated to expand at a rapid pace in the next few years due to an increase in research & development and technologically advanced products being introduced in the market. Europe is expected to be the second-largest market during the forecast period owing to advanced facilities provided by the hospital infrastructure in the region.
• The Atosiban Market in Asia Pacific is likely to expand at a high CAGR during the forecast period owing to the dense population and high birthrate in the region
Request For Custom Research:
https://www.transparencymarketresearch.com/sample/sample.php?flag=C...
Key Players Operating in Global Atosiban Market
The global Atosiban market is highly consolidated owing to the presence of several key players. Leading players operating in the global Atosiban market include:
• Ferring Pharmaceuticals
• Sun Pharma
• Shanghai Soho-Yiming Pharmaceuticals
• EVER Pharma
• Hangzhou Longshine Bio-Tech
• Cayman Chemical
• Neore Pharmaceutical
Global Atosiban Market: Research Scope
Global Atosiban Market, by Type
• Injection
• Concentrate
Global Atosiban Market, by Application
• Preterm labor
• autism or Asperger’s disorder
• Oxidative Stress
• Others
Global Atosiban Market, by End-user
• Hospital Pharmacies
• Online Pharmacies
• Other
Global Atosiban Market, by Region
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia & New Zealand
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Rest of Latin America
• Middle East & Africa
o GCC Countries
o South Africa
o Rest of Middle East & Africa
Pre Book:
https://www.transparencymarketresearch.com/checkout.php?rep_id=8197...
About Us:
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact us:
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/